MetaCap

Precision BioSciences Insider Trades

NASDAQ: DTILHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.72+0.29 (+4.51%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
6 · $63.21K
Sales
11 · $466.17K
Shares bought / sold
11.82K / 113.00K
Net activity
Net selling $402,953

Precision BioSciences insider activity

Over the last 12 months, Precision BioSciences insiders reported 41 transactions on SEC Form 4: 6 open-market purchases and 11 sales. Insiders bought $63,215 and sold $466,167 worth of stock, for net insider selling of $402,953. The largest seller was Amoroso Michael, with $246,183 in reported sales.

The most recent filing shows Frankel Stanley (Director) buying 1,000 shares at $6.00 on Sep 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DTIL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

DTIL insider transactions

Precision BioSciences insider transactions
DateInsiderTypeSharesValueFiling
Sep 28, 2026Frankel StanleyDirectorBuy1,000$6.00KForm 4
Sep 25, 2026Germano Geno JDirectorBuy2,609$16.38KForm 4
Sep 25, 2026Brown MelindaDirectorBuy1,135$7.12KForm 4
May 20, 2026Germano Geno JDirectorOption exercise21,000—Form 4
May 20, 2026Pire Shari LisaDirectorOption exercise21,000—Form 4
May 20, 2026Frankel StanleyDirectorOption exercise21,000—Form 4
May 20, 2026Buehler KevinDirectorOption exercise21,000—Form 4
May 20, 2026Brown MelindaDirectorOption exercise21,000—Form 4
Feb 18, 2026SMITH J. JEFFERSONChief Research OfficerSale4,925$18.91KForm 4
Feb 18, 2026Scimeca DarioGeneral Counsel and SecretarySale4,925$18.91KForm 4
Feb 18, 2026Kelly John AlexanderChief Financial OfficerSale8,149$31.29KForm 4
Feb 18, 2026Amoroso MichaelPresident and CEOSale20,559$78.95KForm 4
Feb 17, 2026SMITH J. JEFFERSONChief Research OfficerOption exercise16,667—Form 4
Feb 17, 2026Scimeca DarioGeneral Counsel and SecretaryOption exercise16,667—Form 4
Feb 17, 2026Kelly John AlexanderChief Financial OfficerOption exercise27,584—Form 4
Feb 17, 2026Amoroso MichaelPresident and CEOOption exercise67,797—Form 4
Jan 22, 2026Amoroso MichaelPresident and CEOSale34,799$145.11KForm 4
Jan 21, 2026Kelly John AlexanderChief Financial OfficerSale15,213$61.31KForm 4
Jan 21, 2026SMITH J. JEFFERSONChief Research OfficerSale10,200$41.11KForm 4
Jan 21, 2026SMITH J. JEFFERSONChief Research OfficerOption exercise16,219—Form 4
Jan 21, 2026Scimeca DarioGeneral Counsel and SecretarySale8,854$35.68KForm 4
Jan 20, 2026Kelly John AlexanderChief Financial OfficerOption exercise26,575—Form 4
Jan 20, 2026Kelly John AlexanderChief Financial OfficerOption exercise13,900—Form 4
Jan 20, 2026Kelly John AlexanderChief Financial OfficerOption exercise3,888—Form 4
Jan 20, 2026Amoroso MichaelPresident and CEOOption exercise69,421—Form 4
Jan 20, 2026Amoroso MichaelPresident and CEOOption exercise37,069—Form 4
Jan 20, 2026Amoroso MichaelPresident and CEOOption exercise8,888—Form 4
Jan 20, 2026SMITH J. JEFFERSONChief Research OfficerOption exercise10,447—Form 4
Jan 20, 2026SMITH J. JEFFERSONChief Research OfficerOption exercise2,500—Form 4
Jan 20, 2026Scimeca DarioGeneral Counsel and SecretaryOption exercise14,908—Form 4
Jan 20, 2026Scimeca DarioGeneral Counsel and SecretaryOption exercise8,425—Form 4
Jan 20, 2026Scimeca DarioGeneral Counsel and SecretaryOption exercise1,978—Form 4
Dec 16, 2025Frankel StanleyDirectorBuy2,700$12.69KForm 4
Dec 16, 2025Germano Geno JDirectorBuy3,000$14.16KForm 4
Dec 15, 2025Brown MelindaDirectorBuy1,381$6.86KForm 4
Nov 3, 2025Scimeca DarioGeneral Counsel and SecretarySale665$4.32KForm 4
Nov 3, 2025Amoroso MichaelPresident and CEOSale3,409$22.12KForm 4
Nov 3, 2025Kelly John AlexanderChief Financial OfficerSale1,303$8.46KForm 4
Nov 2, 2025Scimeca DarioGeneral Counsel and SecretaryOption exercise1,835—Form 4
Nov 2, 2025Amoroso MichaelPresident and CEOOption exercise9,444—Form 4
Nov 2, 2025Kelly John AlexanderChief Financial OfficerOption exercise3,605—Form 4
Sep 26, 2025Frankel StanleyDirectorBuy2,700$13.42KForm 4
Sep 22, 2025Brown MelindaDirectorBuy1,400$6.85KForm 4
Jul 3, 2025Kelly John AlexanderChief Financial OfficerSale14,827$63.16KForm 4
Jun 25, 2025Buehler KevinDirectorBuy5,076$21.12KForm 4
Jun 25, 2025Brown MelindaDirectorBuy1,682$6.96KForm 4
May 27, 2025Buehler KevinDirectorOption exercise9,826—Form 4
May 27, 2025Frankel StanleyDirectorOption exercise9,826—Form 4
May 27, 2025Pire Shari LisaDirectorOption exercise9,826—Form 4
May 27, 2025Germano Geno JDirectorOption exercise9,826—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related